9E Health-Promoting Effects of Wine Phenolics 585
Del Bas, J. M., Fernandez-Larrea, J., Blay, M., Ardevol, A., Salvado, M. J., Arola, L., & Blade, C.
(2005). Grape seed procyanidins improve atherosclerotic risk index and induce liver CYP7A1
and SHP expression in healthy rats.FASEB J., 19, 479–481.
Di Bari, M., Zacchei, S., Kritchevsky, S. B., Anichini, M., Cesaretti, S., Chiarlone, M., Masotti, G.,
& Marchionni, N. (2003). Anti-oxidized LDL antibodies and wine consumption: a population-
based epidemiological study in Dicomano, Italy.Ann. Epidemiol., 13, 189–195.
Donovan, J. L., Bell, J. R., Kasim-Karakas, S., German, J. B., Walzem, R. L., Hansen, R. J., &
Waterhouse, A. L. (1999). Catechin is present as metabolites in humanplasma after consump-
tion of red wine.J. Nutr., 129, 1662–1668.
El Bedoui, J., Oak, M. H., Anglard, P., & Schini-Kerth, V. B. (2005). Catechins prevent vascular
smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression.Cardio-
vasc. Res., 67, 317–325.
Estruch, R., Sacanella, E., Badia, E., Antunez, E., Nicolas, J. M., Fernandez-Sola, J., Rotilio, D.,
de Gaetano, G., Rubin, E., & Urbano-Marquez,A. (2004). Different effects of red wine and
gin consumption on inflammatory biomarkers of atherosclerosis: a prospective randomized
crossover trial. Effects of wine on inflammatory markers.Atherosclerosis, 175, 117–123.
Feng, B., Yao, P. M., Li, Y., Devlin, C. M., Zhang, D., Harding, H. P., Sweeney, M., Rong, J.
X., Kuriakose, G., Fisher, E. A., Marks, A. R., Ron, D., & Tabas, I. (2003). The endoplasmic
reticulum is the site of cholesterol-induced cytotoxicity in macrophages.Nat. Cell Biol., 5,
781–792.
Finkel, T., & Holbrook, N. J. (2000). Oxidants, oxidative stress and the biology of ageing.Nature,
408 , 239–247.
Fontana, L., & Klein, S. (2007). Aging, adiposity, and calorie restriction.JAMA, 297, 986–994.
Fortu ̃no, A., Beloqui, O., San Jose, G., Moreno, M. U., Zalba, G., & Diez, J. (2005). Increased
phagocytic nicotinamide adenine dinucleotide phosphate oxidase-dependent superoxide pro-
duction in patients with early chronic kidney disease.Kidney Inter. Suppl., 99, S71–S75.
Fortu ̃no, A., San Jos ́e, G., Moreno, M. U., Beloqui, O., Diez, J., & Zalba, G. (2006). Phagocytic
NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome.Diabetes, 55,
209–215.
Frank, J., Budek, A., Lundh, T., Parker, R. S., Swanson, J. E., Lourenco, C. F., Gago, B., Laran-
jinha, J., Vessby, B., & Kamal-Eldin, A. (2006). Dietary flavonoids with a catechol structure
increase alpha-tocopherol in rats and protect the vitamin from oxidation in vitro.J. Lipid Res.,
47 , 2718–2725.
Frank, T., Netzel, M., Strass, G., Bitsch, R., & Bitsch, I. (2003). Bioavailability of anthocyanidin-3-
glucosides following consumption of red wine and red grape juice.Can. J. Physiol. Pharmacol.,
81 , 423–435.
Frankel, E. N., Kanner, J., German, J. B., Parks, E., & Kinsella, J. E. (1993). Inhibition ofoxida-
tion of human low-density lipoprotein by phenolic substances in red wine.The Lancet, 341,
454–457.
Fuhrman, B., & Aviram, M. (2002). Preservation of paraoxonase activity by wine flavonoids: pos-
sible role in protection of LDL from lipid peroxidation.Ann. N.Y. Acad. Sci., 957, 321–324.
Fuhrman, B., Lavy, A., & Aviram, M. (1995). Consumption of red wine with meals reduces the
susceptibility of human plasma and low-density lipoprotein to lipid peroxidation.Am. J. Clin.
Nutr., 61 , 549–554.
Garvin, S., Ollinger, K., & Dabrosin, C. (2006). Resveratrol induces apoptosis and inhibits angio-
genesis in human breast cancer xenografts in vivo.Cancer Lett., 231, 113–122.
Gauss, K. A., Nelson-Overton, L. K., Siemsen, D. W., Gao, Y., Deleo, F. R., & Quinn, M. T. (2007).
Role of NF-kappaB in transcriptional regulation of the phagocyte NADPH oxidase by tumor
necrosis factor-alpha.J. Leukocite Biol., 82, 729–741.
Gilmore, T. D. (2006). Introduction to NF-kappaB: players, pathways, perspectives.Oncogene, 25,
6680–6684.
Goldberg, D. M., Yan, J., & Soleas, G. J. (2003). Absorption of three wine-related polyphenols in
three different matrices by healthy subjects.Clin. Biochem., 36, 79–87.